Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 92

1.

Genome-wide expression analysis in Down syndrome: insight into immunodeficiency.

Li C, Jin L, Bai Y, Chen Q, Fu L, Yang M, Xiao H, Zhao G, Wang S.

PLoS One. 2012;7(11):e49130. doi: 10.1371/journal.pone.0049130. Epub 2012 Nov 14.

2.

Identification of dysregulated microRNAs in lymphocytes from children with Down syndrome.

Xu Y, Li W, Liu X, Chen H, Tan K, Chen Y, Tu Z, Dai Y.

Gene. 2013 Nov 10;530(2):278-86. doi: 10.1016/j.gene.2013.07.055. Epub 2013 Aug 8.

PMID:
23933415
3.
4.

Gene expression profiling in the adult Down syndrome brain.

Lockstone HE, Harris LW, Swatton JE, Wayland MT, Holland AJ, Bahn S.

Genomics. 2007 Dec;90(6):647-60. Epub 2007 Oct 22.

5.

Gene therapy for Down syndrome.

Fillat C, Altafaj X.

Prog Brain Res. 2012;197:237-47. doi: 10.1016/B978-0-444-54299-1.00012-1. Review.

PMID:
22541296
6.

Natural gene-expression variation in Down syndrome modulates the outcome of gene-dosage imbalance.

Prandini P, Deutsch S, Lyle R, Gagnebin M, Delucinge Vivier C, Delorenzi M, Gehrig C, Descombes P, Sherman S, Dagna Bricarelli F, Baldo C, Novelli A, Dallapiccola B, Antonarakis SE.

Am J Hum Genet. 2007 Aug;81(2):252-63. Epub 2007 Jun 20.

7.

Mental retardation in Down syndrome: from gene dosage imbalance to molecular and cellular mechanisms.

Rachidi M, Lopes C.

Neurosci Res. 2007 Dec;59(4):349-69. Epub 2007 Aug 15. Review.

PMID:
17897742
8.

Trisomy 21 and Down syndrome: a short review.

Sommer C, Henrique-Silva F.

Braz J Biol. 2008 May;68(2):447-52. Review.

9.

[Screening and identification of human chromosome 21 genes resulting in abnormal development of fetal cerebral cortex with Down syndrome].

Yu WD, Liang R, Yang LJ, Shang M, Shen H, Guan J, Guo JZ.

Zhonghua Yi Xue Za Zhi. 2007 Oct 23;87(39):2759-63. Chinese.

PMID:
18167266
10.

Expression of trisomic proteins in Down syndrome model systems.

Spellman C, Ahmed MM, Dubach D, Gardiner KJ.

Gene. 2013 Jan 10;512(2):219-25. doi: 10.1016/j.gene.2012.10.051. Epub 2012 Oct 26.

PMID:
23103828
11.

Decreased AIRE expression and global thymic hypofunction in Down syndrome.

Lima FA, Moreira-Filho CA, Ramos PL, Brentani H, Lima Lde A, Arrais M, Bento-de-Souza LC, Bento-de-Souza L, Duarte MI, Coutinho A, Carneiro-Sampaio M.

J Immunol. 2011 Sep 15;187(6):3422-30. doi: 10.4049/jimmunol.1003053. Epub 2011 Aug 19.

12.

Genome-wide microRNA expression profiling in placentas of fetuses with Down syndrome.

Lim JH, Kim DJ, Lee DE, Han JY, Chung JH, Ahn HK, Lee SW, Lim DH, Lee YS, Park SY, Ryu HM.

Placenta. 2015 Mar;36(3):322-8. doi: 10.1016/j.placenta.2014.12.020. Epub 2015 Jan 5.

PMID:
25595853
13.

Meta-analysis of heterogeneous Down Syndrome data reveals consistent genome-wide dosage effects related to neurological processes.

Vilardell M, Rasche A, Thormann A, Maschke-Dutz E, Pérez-Jurado LA, Lehrach H, Herwig R.

BMC Genomics. 2011 May 11;12:229. doi: 10.1186/1471-2164-12-229.

14.

Dosage-dependent over-expression of genes in the trisomic region of Ts1Cje mouse model for Down syndrome.

Amano K, Sago H, Uchikawa C, Suzuki T, Kotliarova SE, Nukina N, Epstein CJ, Yamakawa K.

Hum Mol Genet. 2004 Jul 1;13(13):1333-40. Epub 2004 May 11.

PMID:
15138197
15.

Analysis of microRNA expression profile by small RNA sequencing in Down syndrome fetuses.

Xu Y, Li W, Liu X, Ma H, Tu Z, Dai Y.

Int J Mol Med. 2013 Nov;32(5):1115-25. doi: 10.3892/ijmm.2013.1499. Epub 2013 Sep 18.

PMID:
24071828
16.

Genotype-phenotype correlations in Down syndrome identified by array CGH in 30 cases of partial trisomy and partial monosomy chromosome 21.

Lyle R, Béna F, Gagos S, Gehrig C, Lopez G, Schinzel A, Lespinasse J, Bottani A, Dahoun S, Taine L, Doco-Fenzy M, Cornillet-Lefèbvre P, Pelet A, Lyonnet S, Toutain A, Colleaux L, Horst J, Kennerknecht I, Wakamatsu N, Descartes M, Franklin JC, Florentin-Arar L, Kitsiou S, Aït Yahya-Graison E, Costantine M, Sinet PM, Delabar JM, Antonarakis SE.

Eur J Hum Genet. 2009 Apr;17(4):454-66. doi: 10.1038/ejhg.2008.214. Epub 2008 Nov 12.

17.

Molecular genetic analysis of Down syndrome.

Patterson D.

Hum Genet. 2009 Jul;126(1):195-214. doi: 10.1007/s00439-009-0696-8. Epub 2009 Jun 13. Review.

PMID:
19526251
18.

An extra human chromosome 21 reduces mlc-2a expression in chimeric mice and Down syndrome.

Nishigaki R, Shinohara T, Toda T, Omori A, Ichinose S, Itoh M, Shirayoshi Y, Kurimasa A, Oshimura M.

Biochem Biophys Res Commun. 2002 Jul 5;295(1):112-8.

PMID:
12083776
19.

Global hypermethylation in fetal cortex of Down syndrome due to DNMT3L overexpression.

Lu J, Mccarter M, Lian G, Esposito G, Capoccia E, Delli-Bovi LC, Hecht J, Sheen V.

Hum Mol Genet. 2016 May 1;25(9):1714-27. doi: 10.1093/hmg/ddw043. Epub 2016 Feb 23.

20.

Human chromosome 21-derived miRNAs are overexpressed in down syndrome brains and hearts.

Kuhn DE, Nuovo GJ, Martin MM, Malana GE, Pleister AP, Jiang J, Schmittgen TD, Terry AV Jr, Gardiner K, Head E, Feldman DS, Elton TS.

Biochem Biophys Res Commun. 2008 Jun 6;370(3):473-7. doi: 10.1016/j.bbrc.2008.03.120. Epub 2008 Apr 1. Retraction in: Biochem Biophys Res Commun. 2013 Jul 5;436(3):564.

Supplemental Content

Support Center